Weichang’an Formula Inhibits Tumor Growth in Combination with Bevacizumab in a Murine Model of Colon Cancer—Making up for the Deficiency of Bevacizumab by inhibiting VEGFR-1

Aim: Angiogenesis plays an important role in the initiation, development, and metastasis of malignant tumors. Antiangiogenic drugs combined with immune therapy are considered to have a synergistic effect on anti-tumor strategy. Weichang’an formula (WCAF) is a prescription of traditional Chinese medi...

Descripción completa

Detalles Bibliográficos
Autores principales: Pan, Chuan-Fang, Zhang, Xi, Wang, Jing-Wen, Yang, Tao, Zhong, Linda L. D., Shen, Ke-Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7970919/
https://www.ncbi.nlm.nih.gov/pubmed/33746736
http://dx.doi.org/10.3389/fphar.2020.512598

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7970919/
https://www.ncbi.nlm.nih.gov/pubmed/33746736
http://dx.doi.org/10.3389/fphar.2020.512598

Ejemplares similares